Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New prospects for treating muscular dystrophy: Stem cells restore muscle in MD mice

11.07.2003


A study on mice suggests that a type of stem cells found in blood vessels may someday be able to regenerate wasting muscle in muscular dystrophy (MD) patients.



The authors caution that more research must be done before researchers consider applying these findings to humans. Nonetheless, their results provide a possible new direction for efforts that have met largely with frustration thus far. The study appears in the journal Science, published by AAAS, the science society.

The research team, led by Giulio Cossu of the Stem Cell Research Institute, in Milan, and the University of Rome and the Institute of Cell Biology and Tissue Engineering, in Rome, has found that these stem cells can cross from the bloodstream, into muscle tissue. There, they seem to take on a new identity, helping to generate new muscle fibers in mice with MD-like symptoms.


MD is a collection of disorders caused by genetic defects that lead to increasing muscle weakness over time. These disorders currently have no cure.

"Although these results are exciting, we have not cured the mice," Cossu said. "We believe this is a significant step toward therapy, but the question that keeps me awake at night is whether this will work in larger animals."

Cossu’s team conducted its experiments on mice with the same genetic defect that causes one form of MD in humans. If the same stem cells, called "mesoangioblasts," can be collected from human MD patients, and if the cells have the same versatility they do early in life, they may offer a new avenue for treating the disease.

The approach Cossu and his colleagues are envisioning would involve collecting mesoangioblasts from a patient’s blood vessels, genetically "correcting" the cells in the laboratory, allowing them to multiply, and then injecting the cells back into the patient’s bloodstream. The cells would then migrate to the patient’s muscles, and begin producing healthy muscle cells.

Because the cells would be from the patient’s own body, his or her immune system wouldn’t reject them.

Trying to find a therapy for MD "has been a long and frustrating series of exploits," said Cossu.

"There is this problem of delivering the cells, or in the case of gene therapy, the viral vector, to all of the muscles. If you could go through the circulatory system, you would have a way to homogeneously deliver the cells or the vector to all the muscle fibers," he said.

Several key issues must be answered before such a therapy can be developed for humans, according to the Science authors.

First, these particular stem cells are fairly new to scientists. Cossu and his colleagues discovered them approximately a year ago, and are still learning how to identify them and how they function in the body. Thus far, Cossu’s team has only isolated human mesoangioblasts from fetal blood vessels.

More research is also needed for the "genetic correction" step of the therapy, which involves inserting the healthy version of a gene into the stem cell. The lentivirus Cossu used for delivering the gene in his mouse study provided the efficiency the researchers needed, but poses serious safety concerns for humans. Whether the safer retrovirus would be up to the task must still be determined.

When Cossu and his colleagues first identified mesoangioblasts last year, they determined that these cells could differentiate into a variety of cell types, including blood, bone, muscle, and connective tissue. They also found that the cells migrated outside the blood vessel, in response to inflammation.

For the current study, the researchers injected mesoangioblasts into the arteries of mice lacking the alpha sarcoglycan gene. This gene is one of several that, when defective, cause a type of MD called limb-girdle muscular dystrophy.

The researchers detected a significant portion of the normal mesoangioblasts in the muscles downstream of the injected artery. They also experimented with genetically modified mesoangioblasts, restoring healthy versions of alpha sarcoglycan gene to the cells. Three months after a single injection, they found healthy alpha sarcoglycan proteins in the muscles of the treated mice.

When Cossu’s group examined the mice, they found that the treated muscles contained larger and more numerous and apparently normal muscle fibers. The treated animals were also able to walk on a rotating wheel for longer than untreated animals, although not as long as healthy mice.

"I’m convinced this is an important result, but this is still not the therapy -- for the mice or for patients," Cossu said.


Giulio Cossu’s co-authors are Maurilio Sampaolesi, Anna Innocenzi, Rossana Tonlorenzi, and M. Gabriella Cusella De Angelis of the Stem Cell Research Institute in Milan, Italy; M.G.C. De Angelis is also at the University of Pavia, in Pavia, Italy; Yvan Torrente and Nereo Bresolin of Ospedale Maggiore Policlinico, in Milan, Italy; N. Bresolin is also at Istituto E. Medea, Bosisio Parini, in Lecco, Italy; M. Antonietta Pellegrino and Roberto Bottinelli at University of Pavia, in Pavia Italy; and Rita Barresi and Kevin P. Campbell at Howard Hughes Medical Institute and the University of Iowa, in Iowa City, IA. The study was supported by Telethon/Fondazione Zegna, the European Community, Duchenne Parent Project Italia/Compagnia di San Paolo, Muscular Dystrophy Association, Fondazione Istituto Pasteur-Cenci Bolognetti, Associazione Italiana Ricera sul Cancro (AIRC), Agenzia Spaziale Italiana (ASI) and the Italian Ministry of Health.

Ginger Pinholster | EurekAlert!
Further information:
http://www.aaas.org/

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>